ReadyCell News
Stay up-to-date on the latest ReadyCell news, projects and developments.
MDCK II cells overexpressing MDR1 protein. A must assay for drug development.
ReadyCell provides ready-to-use in vitro system for assessing the pharmacological role of the P-gp receptor in preclinical stages.
Pharmacology 2020 Event
ReadyCell actively interacts with the Drug Discovery community, introducing cell-based in vitro systems and easing novel compounds’ preclinical development.
Discover how in vitro Caco-2 cells help you evaluate novel therapeutic molecules
Caco-2 cells are considered a reference cellular model for basic research and drug discovery projects. ReadyCell supplies systems worldwide.
Readycell’s gratitude message
Due to the current situation and special circumstances, ReadyCell’s team would like to thank all healthcare professionals for the huge effort to contain the pandemic, which allows to carry on our daily lives.
PreadyTake MATE1, Screening Renal and Hepatic Drug Metabolism
In vitro systems based on HEK293 cells are a recommended technique to assess MATE1 transporter interactions during preclinical stages.
The latest FDA guidance on in vitro drug-drug interactions is finally out!
Among other things, the agency explains that DDIs are a critical factor in a drug’s overall benefit-risk profile.
Meet us at BioAsia 2020 in India
ReadyCell is happy to announce that its team will be attending this year’s BioAsia Conference taking place from 17 – 19 February 2020 in Hyderabad, India.
ReadyCell at “The In Vitro Choice” Meeting
The speakers list included basic researchers and companies responsibles in the field of safety and toxicity assays.
ReadyCell is proud to receive Nexel in Barcelona
The Readycell team was glad to welcome Nexel’s CEO Dr. Choonseong Han, and Nexel’s Business Manager, Dr. Hayden Lee to visit our facilities in the city of Barcelona.
ReadyCell is proud to receive SOLVO Biotechnology in Barcelona
ReadyCell S.L. was proud to recently welcome our colleagues and partners from SOLVO Biotechnology to our facilities in the Barcelona Science Park.
Participating in the Nordic Life Science Days 2018 in Stockholm, Sweden
ReadyCell has started the last quarter of 2018 participating in the Nordic Life Science Days conference, taking place in Stockholm (Sweden) between the 10th and 12th of September 2018.
Participating in DDI 2018 in Seattle, USA
ReadyCell attended the conference, and met with relevant scientists from many Pharma, Biotech and Academia and discussed the new scenarios within the segment.
Participating in BIOUSA 2018 in Boston, USA
ReadyCell had the chance to meet with Spanish representatives in the Spanish Pavilion, and also with a remarkable number of scientists, Business Developers, and CEO’s of different Pharma, Biotech and CRO companies.
Participating in BioJapan 2017 in Yokohama
ReadyCell’s representatives participated in the BioJapan 2017 held in Yokohama in order to meet local and international companies to penetrate the Japanese market with our unique shipping technologies and ready-to-use kits for ADME studies.
